Expand CTOR Menu
CTOR MENU

CTOR Latest Press Releases

-- January 5, 2026 --

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Citius Oncology, Inc. (NASDQ: CTOR) PRNewswire 10:30 AM

-- December 23, 2025 --

Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update PRNewswire 4:30 PM
Citius Oncology, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update PRNewswire 4:30 PM

-- December 10, 2025 --

Citius Oncology Announces Closing of $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules PRNewswire 4:30 PM

-- December 9, 2025 --

Citius Oncology Announces $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules PRNewswire 8:30 AM

-- December 4, 2025 --

Citius Oncology Expands LYMPHIR Distribution to Turkey and Middle East Countries Through Exclusive Agreement with Er-Kim PRNewswire 8:37 AM
Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations Globe Newswire 8:30 AM

-- December 1, 2025 --

Citius Oncology Announces U.S. Commercial Launch of LYMPHIR , a Novel Cancer Immunotherapy for Cutaneous T-Cell Lymphoma (CTCL) PRNewswire 12:00 PM

-- November 25, 2025 --

Citius Oncology to Exhibit at the 67th American Society of Hematology (ASH) Annual Meeting PRNewswire 8:00 AM

-- November 21, 2025 --

Citius Oncology to Advance Commercial Launch of LYMPHIR with Verix AI Integration PRNewswire 8:37 AM

-- October 20, 2025 --

Citius Oncology Signs U.S. Distribution Agreement with McKesson to Support LYMPHIR Commercial Launch PRNewswire 8:37 AM

-- October 17, 2025 --

Citius Pharmaceuticals and Citius Oncology to Participate in Upcoming October 2025 Conferences PRNewswire 5:00 PM

-- October 16, 2025 --

Citius Oncology Signs Exclusive Commercialization Agreement with EVERSANA to Support Planned Q4 2025 Launch of LYMPHIR PRNewswire 8:47 AM

-- October 7, 2025 --

Citius Oncology Establishes International Access to LYMPHIR via Named Patient Programs in Southern Europe PRNewswire 8:47 AM

-- September 10, 2025 --

Citius Oncology Announces Closing of $9.0 Million Registered Direct Offering and Concurrent Private Placement PRNewswire 4:30 PM

-- September 9, 2025 --

Citius Oncology Announces Pricing of $9.0 Million Registered Direct Offering and Concurrent Private Placement PRNewswire 8:30 AM
Market Data Delayed 15 Minutes